Fertility preservation in women undergoing treatment for malignancies: a narrative review
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20240499Keywords:
Fertility preservation, Young cancer patients, Fertility preserving cancer surgery, Conservative cancer managementAbstract
Incidence of cancer is increasing in young patients with simultaneous improvement in survival secondary to advances in cancer treatment. Fertility preservation in this young population is often overlooked in view of priority of cancer treatment, however it is important to avoid distress and provide a good quality of life in these young patients of child bearing age. Fertility might be affected due to systemic therapy like chemotherapy, radiotherapy and surgery involving reproductive organs. Timely referral to reproductive specialist during the narrow window after diagnosis and before starting cytotoxic treatment is required. Embryo and oocyte cryopreservation remains the gold standard with ovarian tissue cryopreservation and re-transplantation undertaken for special situations. Patients undergoing pelvic or abdominal radiotherapy benefit from ovarian transposition and ovarian shielding. Medical gonado-protection with Gonadotropin releasing hormone agonist during cytotoxic chemotherapy remains an area of controversy with conflicting results with recent consensus for use in premenopausal breast cancer patients. Patients requiring surgery for endometrial cancer, ovarian cancer or cervical cancer may be considered for conservative management including conservative surgery for early stage cancers with specific indications with the intent to allow patients to complete family. Adequate patient counselling for oncology outcomes and fertility preservation are required to enable the patients to take informed decisions to choose the unconventional path of cancer management and uncertainty involving pregnancy and live births.
References
You L, Lv Z, Li C, Ye W, Zhou Y, Jin J, et al. Worldwide cancer statistics of adolescents and young adults in 2019: A systematic analysis of the Global Burden of Disease Study 2019. ESMO Open. 2021;6(5):100255.
Lambertini M, Peccatori F, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines. Ann. Oncol. 2020;31(12):1664-78.
Gupta N, Pandey AK, Dimri K, Jyani G, Goyal A, Prinja S. Health-related quality of life among breast cancer patients in India. Support Care Cancer. 2022;30(12):9983-90.
Ussher JM, Cummings J, Dryden A and Perz J. Talking about fertility in the context of cancer: health care professional perspectives. Eur J Cancer Care. 2016;25(1):99-111.
Hershberger PE, Finnegan L, Pierce PF, Scoccia B. The decision-making process of young adult women with cancer who considered fertility cryopreservation. J Obstet Gynecol Neonatal Nurs. 2013;42(1):59-69.
National Health Authority. National Health Benefit Package 2.2. Available at: https://nha.gov.in/ img/resources/HBP-2.2-manual.pdf. Accessed on 17 September 2023.
Santaballa A, Márquez Vega C, Rodríguez Lescure A, Rovirosa A, Vázquez L, Zeberio Etxetxipia I, et al. Multidisciplinary consensus on the criteria for fertility preservation in cancer patients. Clin Transl Oncol. 2022;24(2):227-43.
Dolmansa MM, Lambertini M, Macklond KT, Santose TA, Ruiz-Casado A, Borinig A, et al. European REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialists. Critical Reviews in Oncol Hematol. 2019;138:233-40.
Dezellus A, Barriere P, Campone M, Lemanski C, Vanlemmens L, Mignot L, et al. Prospective evaluation of serum anti-Mullerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer. Eur J Cancer. 2017;79:72-80.
Younis JS, Ben-Ami M, Ben-Shlomo I. The Bologna criteria for poor ovarian response: a contemporary critical appraisal. J Ovarian Res. 2015;8:76.
Taylan E, Oktay KH. Current state and controversies in fertility preservation in women with breast cancer. World J Clin Oncol. 2017;8(3):241-8.
Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25(6):673-93.
Zhao J, Liu J, Chen K, Li S, Wang Y, Yang Y, et al. What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Res Treat. 2014;145(1):113-28.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, et al. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. N Engl J Med. 2023;388(18):1645-56.
Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages. Hum Reprod Update. 2009;15(3):359-77.
Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91(5):1723-8.
Critchley HO, Wallace WH, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol. 1992;99(5):392-4.
Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation with Tamoxifen and Letrozole for Embryo Cryopreservation. J Clin Oncol. 2005;23(19):4347-53.
Arecco L, Blondeaux E, Bruzzone M, Ceppi M, Latocca MM, Marrocco C, et al. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: A systematic review and meta-analysis. Hum Reprod. 2022;37(5):954-68.
Dolmans MM, Hollanders de Ouderaen S, Demylle D, Pirard C. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet. 2015;32(8):1233-7.
Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocytes vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755-64.
Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I, et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018;109(3):478-85.
Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377(17):1657-65.
Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol. 2018;36(19):1981-90.
Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):77-86.
Gilani MM, Hasanzadeh M, Ghaemmaghami F, Ramazanzadeh F. Ovarian preservation with gonadotropin-releasing hormone analogue during chemotherapy. Asia Pac J Clin Oncol. 2007;3(2):79-83.
Irtan S, Orbach D, Helfre S and Sarnacki S. Ovarian transposition in prepubescent and adolescent girls with cancer. Lancet Oncol. 2013;14(13):e601-8.
Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J Ovarian Res. 2014;7:69.
Hwang JH, Yoo HJ, Park SH, Lim MC, Seo SS, Kang S, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril. 2012;97(6):1387-93.
Karami V, Zabihzadeh M, Shams N, Malehi AS. Gonad shielding during pelvic radiography: a systematic review and meta-analysis. Arch Iran Med. 2017;20(2):113-23.
Lambertini M, Goldrat O, Ferreira AR, Dechene J, Azim Jr HA, Desir J, et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients. Ann Oncol. 2018;29(1):237-43.
Lambertini M, Ameye L, Hamy A-S, Zingarello A, Poorvu PD, Carrasco E, et al. Pregnancy after breast cancer in patients with germline BRCA mutations. J Clin Oncol. 2020;38(26):3012-23.
National Comprehensive Cancer Network. Available at: https://www.nccn.org/login?ReturnURL=https:// www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf. Accessed on 17 September 2023.
Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin J, Pautier P, et al. Non epithelial ovarian cancers: ESMO clinical practice guidelines for diagnosis, treatment and follow up. Ann Oncol. 2018;29(4):1-18.
International Agency for Research on Cancer. Cancer today. 2020. Available at: https:// gco.iarc.fr/ today/home. Accessed on 17 September 2023.
Nakamura K, Banno K, Yanokura M, Lida M, Adachi M, Masuda K, et al. Features of ovarian cancer in Lynch syndrome (review). Mol Clin Oncol. 2014;2(6):909-16.
Gallo A, Catena U, Saccone G, Sardo ADS. Conservative surgery in endometrial cancer. J Clin Med. 2021;11(1):183.
Piatek S, Michalski W, Sobiczewski P, Bidzinski M, Szewczyk G. The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: case series of 30 patients and systematic review. Eur J Obstet Gynecol Reprod Biol. 2021;263:139-47.
Roh HJ, Yoon HJ, Jeong DH, Lee TH, Kwon BS, Suh DS, et al. Prognostic factors of oncologic outcomes after fertility-preservative management with progestin in early-stage of endometrial cancer. J Res Med Sci. 2021;26:48.
Herrera Cappelletti E, Humann J, Torrejón R, Gambadauro P. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis. Hum Reprod Update. 2022;28(2):282-95.
National Comprehensive Cancer Network. Available at: https://www.nccn.org/professionals/physician_ gls/pdf/cervical.pdf V1.2024. Accessed on 17 September 2023.
Smith ES, Moon AS, O’Hanlon R, Leitao MM, Sonoda Y, Abu Rustum NR,et al. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020;136:533-42.
Schmeler KM, Pareja R, Lopez Blanco A, Fregnani JH, Lopes A, Perrotta M, et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer. Int J Gynecol Cancer. 2021;31(10):1317-25.
Hartnett KP, Mertens AC, Kramer MR, Lash TL, Spencer JB, Ward KC, et al. Pregnancy after cancer: does timing of conception affect infant health? Cancer. 2018;124(22):4401-7.
van der Kooi A-LLF, Kelsey TW, van den Heuvel-Eibrink MM, Laven JSE, Wallace WHB, Anderson RA. Perinatal complications in female survivors of cancer: a systematic review and meta-analysis. Eur J Cancer. 2019;111:126-37.
